Rice bran peptides with α-glucosidase inhibition activity delay the in vitro starch digestion of different rice foods
Fuan Wang1, Meng Du1, Gengjie Cui1
1Key Laboratory of Geriatric Nutrition and Health (Beijing Technology and Business University), Ministry of Education, Beijing 100048, China.
Abstract:
Rice bran peptides (RBPs) with α-glucosidase inhibition activity have shown great efficacy in reducing postprandial blood glucose levels. This study investigated the inhibitory mechanism of RBPs on amyloglucosidase (AMG) and their potential for modulating starch digestion in rice-based foods. The results demonstrated that RBPs significantly reduced the digestibility and estimated glycemic index (eGI) values of all rice foods in a dose-dependent manner. Fourier transform infrared (FTIR) spectroscopy revealed that interactions between RBPs and AMG resulted in significant alterations to AMG's secondary structure, characterized by a 20.31 ± 0.01 % decrease in α-helical content and a 59.33 ± 0.01 % increase in β-sheet content compared to the control. Moreover, the size exclusion chromatography (SEC) weight distribution curve further illustrated that RBPs delayed the hydrolysis of starch macromolecules, enabling them to remain in a higher molecular weight state during digestion. Molecular docking revealed that RBPs interact with critical catalytic residues via hydrogen bonding and electrostatic forces, directly obstructing substrate access to AMG's active site. In summary, RBPs altered the secondary structure of AMG, inhibited enzyme activity, and thereby delayed starch digestion. These findings further explain the possible mechanism of peptide effects on starch digestion and have important implications for the development of functional carbohydrate foods aimed at delaying starch digestion.
More Related Videos
09:43Author Spotlight: Streamlining Rice Breeding with CRISPR/Cas for Obtaining Optimal Phenotypic and Agronomic Traits
Published on: January 3, 2025
09:21Inhibition of Aspergillus flavus Growth and Aflatoxin Production in Transgenic Maize Expressing the α-amylase Inhibitor from Lablab purpureus L.
Published on: February 15, 2019
Related Concept Videos
Carbohydrate Digestion
Dipeptidyl Peptidase 4 Inhibitors
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
